Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Maggie, Czarnogorski"'
Autor:
Cassidy A. Gutner PhD, Marc van der Valk MD, PhD, Joaquin Portilla MD, Eliette Jeanmaire MD, Leïla Belkhir MD, PhD, Thomas Lutz MD, Rebecca DeMoor MSc, Rekha Trehan BSc, Jenny Scherzer MBA, MSc, Miguel Pascual-Bernáldez PharmB, Mounir Ait-Khaled PhD, Beatriz Hernandez PharmD, PhD, Annemiek de Ruiter MBBS, FRCP, Savita Bakhshi Anand PhD, Emma L. Low PhD, Monica Hadi PhD, Nicola Barnes MA, Nick Sevdalis PhD, Perry Mohammed MBBS, Maggie Czarnogorski MD, MPH
Publikováno v:
Journal of the International Association of Providers of AIDS Care, Vol 23 (2024)
Introduction CARISEL is an implementation–effectiveness “hybrid” study examining the perspectives of people living with HIV-1 (patient study participants [PSPs]) on cabotegravir (CAB) plus rilpivirine (RPV) long-acting (LA) dosed every 2 months
Externí odkaz:
https://doaj.org/article/5d90730f2456430790ded91fab079d5b
Autor:
Cassidy A. Gutner, Laurent Hocqueloux, Celia Jonsson‐Oldenbüttel, Linos Vandekerckhove, Berend J. vanWelzen, Laurence Slama, María Crusells‐Canales, Julián Olalla Sierra, Rebecca DeMoor, Jenny Scherzer, Mounir Ait‐Khaled, Gilda Bontempo, Martin Gill, Natasha Patel, Ronald D'Amico, Kai Hove, Bryan Baugh, Nicola Barnes, Monica Hadi, Emma L. Low, Savita Bakhshi Anand, Alison Hamilton, Harmony P. Garges, Maggie Czarnogorski
Publikováno v:
Journal of the International AIDS Society, Vol 27, Iss 7, Pp n/a-n/a (2024)
Abstract Introduction Cabotegravir plus rilpivirine (CAB + RPV) is the first complete long‐acting (LA) regimen recommended for maintaining HIV‐1 virological suppression. Cabotegravir And Rilpivirine Implementation Study in European Locations (CAR
Externí odkaz:
https://doaj.org/article/cf663c19fbc04c13b44fe74a60666e97
Autor:
Andrea Mantsios, Miranda Murray, Tahilin S. Karver, Wendy Davis, Noya Galai, Princy Kumar, Susan Swindells, U. Fritz Bredeek, Rafael Rubio García, Antonio Antela, Santiago Cenoz Gomis, Miguel Pascual Bernáldez, Maggie Czarnogorski, Krischan Hudson, Nicki Walters, Deanna Kerrigan
Publikováno v:
BMC Health Services Research, Vol 21, Iss 1, Pp 1-14 (2021)
Abstract Background Long-acting injectable antiretroviral therapy (LA ART) has been shown to be non-inferior to daily oral ART, with high patient satisfaction and preference to oral standard of care in research to date, and has recently been approved
Externí odkaz:
https://doaj.org/article/9e71a923e6fb41a7abd953d3f6b71e1e
Autor:
Maggie, Czarnogorski, Paul, Benn, Cindy, McCoig, Toyin, Nwafor, Sandy, Griffith, Ken, Sutton, Conn, Harrington, Parminder, Saggu, Itziar, Yague, Will, Williams, Carlos M, Español, Jessica, Goodchild, Jane, Fricker, Parul, Patel, Ronald, D'Amico
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 91:157-161
Cabotegravir + rilpivirine long-acting (LA) is a novel antiretroviral therapy (ART) administered intramuscularly monthly or every 2 months by a health care provider. The COVID-19 pandemic presents a potential challenge to patients' ability to attend
Autor:
Stephane De Wit, Agathe Rami, Fabrice Bonnet, Rebecca DeMoor, Gilda Bontempo, Christine Latham, Martin Gill, Monica Hadi, Owen Cooper, Savita Bakhshi Anand, Cassidy Gutner, Mounir Ait-Khaled, Jean A van Wyk, Maggie Czarnogorski
Publikováno v:
Open Forum Infectious Diseases. 9
Background Cabotegravir + Rilpivirine Long Acting (CAB+RPV LA) every 2 months is a recommended regimen in European and US treatment guidelines for PLWH with virological suppression and no known resistance to CAB or RPV. CARISEL, an implementation stu
Autor:
Cindy P, Garris, Maggie, Czarnogorski, Marybeth, Dalessandro, Ronald, D'Amico, Toyin, Nwafor, Will, Williams, Deanna, Merrill, YuanYuan, Wang, Larissa, Stassek, Michael B, Wohlfeiler, Gary I, Sinclair, Leandro A, Mena, Blair, Thedinger, Jason A, Flamm, Paul, Benson, William R, Spreen
Publikováno v:
Journal of the International AIDS Society. 25
The CUSTOMIZE hybrid III implementation-effectiveness study evaluated implementation of once-monthly long-acting (LA) cabotegravir + rilpivirine in diverse US healthcare settings. Here, we report patient participant perspectives after 12 months in CU
Autor:
Maggie Czarnogorski, Cindy P. Garris, Marybeth Dalessandro, Ronald D'Amico, Toyin Nwafor, Will Williams, Deanna Merrill, YuanYuan Wang, Larissa Stassek, Michael B. Wohlfeiler, Gary I. Sinclair, Leandro A. Mena, Blair Thedinger, Jason A. Flamm, Paul Benson, William R. Spreen
Publikováno v:
Journal of the International AIDS Society. 25(9)
CUSTOMIZE evaluated the implementation of long-acting (LA) cabotegravir + rilpivirine, a novel healthcare provider-administered injectable antiretroviral therapy regimen, in diverse US healthcare settings. Findings from staff-study participants (SSPs
Autor:
Katherine M. Iverson, Galina A. Portnoy, Sally G. Haskell, Megan R. Gerber, Maggie Czarnogorski
Publikováno v:
Public Health Rep
Objective The Veterans Health Administration established comprehensive women’s health clinics (CWHCs) to provide coordinated, high-quality primary care to women veterans. Intimate partner violence (IPV) is prevalent among women using these clinics.
Autor:
Rafael Rubio García, U. Fritz Bredeek, Noya Galai, Maggie Czarnogorski, Wendy Davis, Deanna Kerrigan, Miranda Murray, Princy Kumar, Antonio Antela, Nicki Walters, Santiago Cenoz Gomis, Krischan J Hudson, Miguel Pascual Bernáldez, Susan Swindells, Tahilin S. Karver, Andrea Mantsios
Publikováno v:
BMC Health Services Research
BMC Health Services Research, Vol 21, Iss 1, Pp 1-14 (2021)
BMC Health Services Research, Vol 21, Iss 1, Pp 1-14 (2021)
Background Long-acting injectable antiretroviral therapy (LA ART) has been shown to be non-inferior to daily oral ART, with high patient satisfaction and preference to oral standard of care in research to date, and has recently been approved for use
Autor:
Kendall J. Bryant, Maggie Czarnogorski, Theresa E Matson, Anna D. Rubinsky, Madeline C. Frost, Derek D. Satre, David A. Fiellin, E. Jennifer Edelman, Emily C. Williams, Kathleen A. McGinnis, Amy C. Justice, Kara M. Bensley, Sheryl L. Catz
Publikováno v:
AIDS. 32:2247-2253
OBJECTIVES To investigate whether gender is associated with three recommended stages of the HIV care continuum and whether gender modifies known associations between level of alcohol use and HIV care among US veterans. DESIGN Retrospective cohort. ME